Rigel Announces Pricing Of Common Stock Offering

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) on 4/19/18 announced the pricing of its previously announced underwritten public offering of 16,000,000 shares of its common stock, offered at a price of $3.90 per share to the public.  The gross proceeds to Rigel from this offering are expected to be $62.4 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Rigel.